In preemptive strike, Sanders, Cummings demand PTC chief Peltz spell out his price for controversial Duchenne MD treatment
It’s time for Stuart Peltz to take the Congressional hot seat on drug pricing.
The CEO of PTC Therapeutics acquired Marathon’s steroid deflazacort for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
